Michael Klukinov, MD
VP of Computational Biology
Michael brings a rare combination of medical training, more than 20 years of programming expertise, and extensive experience in biomedical research and computational biology. A research scientist at Stanford University prior to join Core Bio, he has spent over two decades investigating molecular mechanisms of disease and developing novel therapeutic approaches. His expertise spans systems biology, gene regulatory network inference, computational modeling, and transcription factor biology. As a co-founder of Core Biotherapeutics, Michael architected the computational framework underlying the company’s drug discovery platform, including a library of transcription factor networks derived from more than 11,500 patients. His work bridges medicine, advanced computational science, and therapeutic discovery to enable the identification of disease-driving transcription factors and the development of novel targeted therapies.